vs
Side-by-side financial comparison of Civeo Corp (CVEO) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $85.1M, roughly 1.9× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -4.0%, a 26.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 7.1%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $14.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -1.4%).
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CVEO vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $161.6M | $85.1M |
| Net Profit | $-6.5M | $19.4M |
| Gross Margin | 22.7% | — |
| Operating Margin | -0.1% | 17.3% |
| Net Margin | -4.0% | 22.8% |
| Revenue YoY | 7.1% | 8508900.0% |
| Net Profit YoY | 58.1% | 139.1% |
| EPS (diluted) | $-0.58 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $161.6M | $85.1M | ||
| Q3 25 | $170.5M | $90.0K | ||
| Q2 25 | $162.7M | $15.0K | ||
| Q1 25 | $144.0M | $14.0K | ||
| Q4 24 | $151.0M | $1.0K | ||
| Q3 24 | $176.3M | $3.0K | ||
| Q2 24 | $188.7M | $5.0K | ||
| Q1 24 | $166.1M | $28.0K |
| Q4 25 | $-6.5M | $19.4M | ||
| Q3 25 | $-455.0K | $-56.9M | ||
| Q2 25 | $-3.3M | $-54.7M | ||
| Q1 25 | $-9.8M | $-48.0M | ||
| Q4 24 | $-15.4M | — | ||
| Q3 24 | $-5.1M | $-43.8M | ||
| Q2 24 | $8.2M | $-35.0M | ||
| Q1 24 | $-5.1M | $-32.4M |
| Q4 25 | 22.7% | — | ||
| Q3 25 | 25.7% | — | ||
| Q2 25 | 25.3% | — | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 18.6% | — | ||
| Q3 24 | 21.4% | — | ||
| Q2 24 | 25.4% | — | ||
| Q1 24 | 21.5% | — |
| Q4 25 | -0.1% | 17.3% | ||
| Q3 25 | 4.1% | -67983.3% | ||
| Q2 25 | 1.7% | -396373.3% | ||
| Q1 25 | -3.8% | -383007.1% | ||
| Q4 24 | -6.7% | — | ||
| Q3 24 | 0.0% | -1704400.0% | ||
| Q2 24 | 6.9% | -849120.0% | ||
| Q1 24 | -1.1% | -136200.0% |
| Q4 25 | -4.0% | 22.8% | ||
| Q3 25 | -0.3% | -63195.6% | ||
| Q2 25 | -2.0% | -364386.7% | ||
| Q1 25 | -6.8% | -342657.1% | ||
| Q4 24 | -10.2% | — | ||
| Q3 24 | -2.9% | -1461433.3% | ||
| Q2 24 | 4.4% | -699060.0% | ||
| Q1 24 | -3.1% | -115717.9% |
| Q4 25 | $-0.58 | $0.43 | ||
| Q3 25 | $-0.04 | $-1.01 | ||
| Q2 25 | $-0.25 | $-0.98 | ||
| Q1 25 | $-0.72 | $-0.86 | ||
| Q4 24 | $-1.04 | — | ||
| Q3 24 | $-0.36 | $-0.79 | ||
| Q2 24 | $0.56 | $-0.63 | ||
| Q1 24 | $-0.35 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $174.4M | $505.7M |
| Total Assets | $477.4M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $402.7M | ||
| Q3 25 | $12.0M | $305.1M | ||
| Q2 25 | $14.6M | $293.2M | ||
| Q1 25 | $28.4M | $321.4M | ||
| Q4 24 | $5.2M | $424.9M | ||
| Q3 24 | $17.9M | $501.9M | ||
| Q2 24 | $7.4M | $541.9M | ||
| Q1 24 | $16.8M | $525.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $43.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $174.4M | $505.7M | ||
| Q3 25 | $182.5M | $369.0M | ||
| Q2 25 | $209.4M | $420.9M | ||
| Q1 25 | $220.7M | $469.7M | ||
| Q4 24 | $236.4M | $510.6M | ||
| Q3 24 | $282.2M | $552.9M | ||
| Q2 24 | $297.4M | $588.3M | ||
| Q1 24 | $297.4M | $600.6M |
| Q4 25 | $477.4M | $566.7M | ||
| Q3 25 | $491.1M | $424.0M | ||
| Q2 25 | $508.8M | $473.6M | ||
| Q1 25 | $423.8M | $515.7M | ||
| Q4 24 | $405.1M | $560.4M | ||
| Q3 24 | $477.6M | $604.0M | ||
| Q2 24 | $483.2M | $620.1M | ||
| Q1 24 | $513.1M | $629.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $28.6M |
| Free Cash FlowOCF − Capex | $14.5M | $28.5M |
| FCF MarginFCF / Revenue | 8.9% | 33.5% |
| Capex IntensityCapex / Revenue | 3.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $28.6M | ||
| Q3 25 | $13.8M | $-46.5M | ||
| Q2 25 | $-2.3M | $-43.4M | ||
| Q1 25 | $-8.4M | $-47.8M | ||
| Q4 24 | $9.5M | $-134.6M | ||
| Q3 24 | $35.7M | $-29.4M | ||
| Q2 24 | $32.4M | $-30.2M | ||
| Q1 24 | $6.0M | $-29.1M |
| Q4 25 | $14.5M | $28.5M | ||
| Q3 25 | $8.2M | $-46.6M | ||
| Q2 25 | $-6.8M | $-43.4M | ||
| Q1 25 | $-13.7M | $-48.4M | ||
| Q4 24 | $1.8M | $-138.4M | ||
| Q3 24 | $28.2M | $-31.2M | ||
| Q2 24 | $27.0M | $-30.6M | ||
| Q1 24 | $372.0K | $-29.8M |
| Q4 25 | 8.9% | 33.5% | ||
| Q3 25 | 4.8% | -51765.6% | ||
| Q2 25 | -4.2% | -289620.0% | ||
| Q1 25 | -9.5% | -345635.7% | ||
| Q4 24 | 1.2% | -13837100.0% | ||
| Q3 24 | 16.0% | -1038966.7% | ||
| Q2 24 | 14.3% | -611840.0% | ||
| Q1 24 | 0.2% | -106421.4% |
| Q4 25 | 3.0% | 0.1% | ||
| Q3 25 | 3.3% | 101.1% | ||
| Q2 25 | 2.8% | 440.0% | ||
| Q1 25 | 3.7% | 4507.1% | ||
| Q4 24 | 5.1% | 378600.0% | ||
| Q3 24 | 4.2% | 59266.7% | ||
| Q2 24 | 2.8% | 6980.0% | ||
| Q1 24 | 3.4% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
